<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Bespoke: How AI is Ushering in the Era of Precision Genetics | SXSW 2026</title>
  <meta name="description" content="Event detail page for Bespoke: How AI is Ushering in the Era of Precision Genetics.">
  <meta name="robots" content="index,follow,max-snippet:-1,max-image-preview:large,max-video-preview:-1">
  <link rel="canonical" href="https://sxsw.0fn.net/schedule/event/PP1162227.html">
  <meta property="og:type" content="website">
  <meta property="og:title" content="Bespoke: How AI is Ushering in the Era of Precision Genetics | SXSW 2026">
  <meta property="og:description" content="Event detail page for Bespoke: How AI is Ushering in the Era of Precision Genetics.">
  <meta property="og:url" content="https://sxsw.0fn.net/schedule/event/PP1162227.html">
  <meta property="og:image" content="https://sxsw.0fn.net/schedule/og-default.svg">
  <meta name="twitter:card" content="summary_large_image">
  <meta name="twitter:title" content="Bespoke: How AI is Ushering in the Era of Precision Genetics | SXSW 2026">
  <meta name="twitter:description" content="Event detail page for Bespoke: How AI is Ushering in the Era of Precision Genetics.">
  <meta name="twitter:image" content="https://sxsw.0fn.net/schedule/og-default.svg">
  <link rel="stylesheet" href="/schedule/styles.css">
</head>
<body>
  <main><p class="breadcrumbs"><a href="/index.html">Home</a> / <a href="/schedule/index.html">Schedule</a> / <a href="/schedule/date/2026-03-17.html">Tue, Mar 17, 2026</a></p>
<section class="hero">
  <h1>Bespoke: How AI is Ushering in the Era of Precision Genetics</h1>
  <p class="meta mono">Event ID: PP1162227</p>
  <p class="meta">Tue, Mar 17, 2026 | 9:00 PM - 10:00 PM</p>
  <p class="meta">Venue: Salon C (JW Marriott)</p>
  <p><a class="button" href="https://schedule.sxsw.com/2026/events/PP1162227" target="_blank" rel="noopener noreferrer">View on Official SXSW</a></p>
</section>
<section class="panel">
  <h2>Summary</h2>
  <p>The pioneering base-editing method of Alexis Komor, PhD, was recently used to create a custom therapy for an infant with carbamoyl phosphate synthetase 1, a deadly rare disease. Her colleague, Gene Yeo, PhD, favors another new approach: RNA-targeting precision therapeutics, which he used to target ALS &amp; aid a child with developmental epileptic encephalopathy. Both employ AI to discover the roots of polygenic diseases—from the ultra-common like diabetes &amp; heart disease to the ultra-rare—&amp; decode the Dark Genome. More on the promise the technology holds for the future of personalized treatment.</p>
  <ul class="flat">
    <li><strong>Format:</strong> Presentation</li>
    <li><strong>Category:</strong> Presentation</li>
    <li><strong>Event Type:</strong> panel</li>
    <li><strong>Presented By:</strong> n/a</li>
  </ul>
</section>
<section class="panel"><h2>Contributors</h2><ul class="flat"><li>Dr. Gene Yeo, PhD, MBA</li><li>Dr. Alexis Komor, PhD</li></ul></section>
<section class="panel">
  <h2>Raw Event JSON</h2>
  <p class="small">Large nested arrays are compacted for page readability. Full payload remains in dataset files.</p>
  <details>
    <summary>Open JSON payload</summary>
    <pre>{
  &quot;id&quot;: &quot;PP1162227&quot;,
  &quot;track&quot;: &quot;Health&quot;,
  &quot;focus_area&quot;: null,
  &quot;category&quot;: &quot;Presentation&quot;,
  &quot;event_id&quot;: &quot;PP1162227&quot;,
  &quot;event_type&quot;: &quot;panel&quot;,
  &quot;format&quot;: &quot;Presentation&quot;,
  &quot;genre&quot;: null,
  &quot;subgenre&quot;: null,
  &quot;name&quot;: &quot;Bespoke: How AI is Ushering in the Era of Precision Genetics&quot;,
  &quot;presented_by&quot;: null,
  &quot;publish_at&quot;: &quot;2025-11-03T16:30:00.000-06:00&quot;,
  &quot;reservable&quot;: true,
  &quot;reservable_id&quot;: &quot;PP1162227&quot;,
  &quot;reserved&quot;: false,
  &quot;date&quot;: &quot;2026-03-17&quot;,
  &quot;end_time&quot;: &quot;2026-03-17T17:00:00.000-05:00&quot;,
  &quot;start_time&quot;: &quot;2026-03-17T16:00:00.000-05:00&quot;,
  &quot;message&quot;: null,
  &quot;image&quot;: null,
  &quot;credentials&quot;: [
    {
      &quot;name&quot;: &quot;Platinum Badge&quot;,
      &quot;type&quot;: &quot;platinum&quot;
    },
    {
      &quot;name&quot;: &quot;Innovation Badge&quot;,
      &quot;type&quot;: &quot;innovation&quot;
    }
  ],
  &quot;contributors&quot;: [
    {
      &quot;id&quot;: 77886,
      &quot;company&quot;: &quot;Sanford Stem Cell Innovation Center&quot;,
      &quot;credential_types&quot;: [
        &quot;innovation&quot;
      ],
      &quot;entity_id&quot;: 2238838,
      &quot;name&quot;: &quot;Dr. Gene Yeo, PhD, MBA&quot;,
      &quot;speaker_types&quot;: [],
      &quot;title&quot;: &quot;Director&quot;,
      &quot;image&quot;: {
        &quot;alt_text&quot;: &quot;Gene Yeo&quot;,
        &quot;credit&quot;: &quot;&quot;,
        &quot;url&quot;: &quot;https://images.sxsw.com/9obuNPaqaivwNFbvE8LPZNZZzBE=/0x0:400x400/600x600/images.sxsw.com/48/02f46ade-1f77-425c-b2c6-8460afbc8173/pcid-1622804&quot;
      },
      &quot;speaker_type&quot;: &quot;Speaker&quot;,
      &quot;details&quot;: &quot;Gene Yeo, PhD, MBA, is a professor of cellular &amp; molecular medicine at UC San Diego, director of its Center for RNA Technologies &amp; Therapeutics, chief scientific advisor of its Sanford Laboratories for Innovative Medicines, &amp; director of its Sanford Stem Cell Innovation Center at the Sanford Stem Cell Institute. He leads a multidisciplinary team that employs high-throughput genomics; systems biology approaches; engineering &amp; statistical &amp; machine learning methods; &amp; biochemical, molecular, &amp; stem cell biology techniques to solve problems in RNA processing. Yeo’s lab develops methods that are systematic, robust, &amp; adoptable, such as STAMP technology, the first transcriptome-wide method for identifying RNA binding protein sites &amp; translation measurements at single-cell resolution.&quot;,
      &quot;links&quot;: {},
      &quot;type&quot;: &quot;person&quot;
    },
    {
      &quot;id&quot;: 77884,
      &quot;company&quot;: &quot;Sanford Stem Cell Innovation Center&quot;,
      &quot;credential_types&quot;: [
        &quot;innovation&quot;
      ],
      &quot;entity_id&quot;: 2238836,
      &quot;name&quot;: &quot;Dr. Alexis Komor, PhD&quot;,
      &quot;speaker_types&quot;: [],
      &quot;title&quot;: &quot;Deputy Director&quot;,
      &quot;image&quot;: {
        &quot;alt_text&quot;: &quot;Alexis Komor&quot;,
        &quot;credit&quot;: &quot;&quot;,
        &quot;url&quot;: &quot;https://images.sxsw.com/IAIErCXsNb5bHVenZBvTL4Zsgjs=/37x72:301x336/600x600/images.sxsw.com/48/ce2d55cd-fc59-477d-ab0a-1e9ef130d6ed/pcid-1622803&quot;
      },
      &quot;speaker_type&quot;: &quot;Speaker&quot;,
      &quot;details&quot;: &quot;Alexis Komor, PhD, is an associate professor in the Department of Chemistry &amp; Biochemistry at UC San Diego, &amp; the deputy director of its Sanford Stem Cell Innovation Center at the UC San Diego Sanford Stem Cell Institute. Komor seeks to integrate the fields of nucleic acid chemistry, DNA damage &amp; repair, protein engineering, directed evolution, &amp; genome editing to develop new laboratory-based methods that facilitate the functional characterization of human genetic variants. She&#39;s received numerous awards &amp; accolades, including a “40 under 40” recognition in healthcare by Fortune magazine in 2020, a \&quot;20(+1) under 40\&quot; recognition as one of the \&quot;next generation of biotech leaders\&quot; by Endpoints News in 2021, &amp; one of 20 scientists leading \&quot;a new generation of gene editors\&quot; by STAT in 2024.&quot;,
      &quot;links&quot;: {},
      &quot;type&quot;: &quot;person&quot;
    }
  ],
  &quot;venue&quot;: {
    &quot;accessible&quot;: false,
    &quot;age_policy&quot;: null,
    &quot;floor&quot;: &quot;3&quot;,
    &quot;id&quot;: &quot;V0453&quot;,
    &quot;indoor_outdoor&quot;: &quot;INDOOR&quot;,
    &quot;name&quot;: &quot;Salon C&quot;,
    &quot;parent_id&quot;: &quot;V0403&quot;,
    &quot;parent_venue_name&quot;: &quot;JW Marriott&quot;,
    &quot;venue_entry_info&quot;: null,
    &quot;formats&quot;: null,
    &quot;location&quot;: {
      &quot;address&quot;: &quot;110 E 2nd St.&quot;,
      &quot;lat_lon&quot;: [
        30.2645713,
        -97.743198
      ],
      &quot;city&quot;: &quot;Austin&quot;,
      &quot;postal_code&quot;: &quot;78701&quot;,
      &quot;state&quot;: &quot;TX&quot;,
      &quot;name&quot;: &quot;JW Marriott&quot;
    },
    &quot;root&quot;: {
      &quot;accessible&quot;: null,
      &quot;age_policy&quot;: null,
      &quot;floor&quot;: null,
      &quot;id&quot;: &quot;V0403&quot;,
      &quot;indoor_outdoor&quot;: null,
      &quot;name&quot;: &quot;JW Marriott&quot;,
      &quot;parent_id&quot;: null,
      &quot;parent_venue_name&quot;: null,
      &quot;venue_entry_info&quot;: null,
      &quot;formats&quot;: null
    },
    &quot;events&quot;: &quot;[omitted 5 venue events]&quot;
  },
  &quot;description&quot;: &quot;The pioneering base-editing method of Alexis Komor, PhD, was recently used to create a custom therapy for an infant with carbamoyl phosphate synthetase 1, a deadly rare disease. Her colleague, Gene Yeo, PhD, favors another new approach: RNA-targeting precision therapeutics, which he used to target ALS &amp; aid a child with developmental epileptic encephalopathy. Both employ AI to discover the roots of polygenic diseases—from the ultra-common like diabetes &amp; heart disease to the ultra-rare—&amp; decode the Dark Genome. More on the promise the technology holds for the future of personalized treatment.&quot;,
  &quot;experience_level&quot;: &quot;Beginner&quot;,
  &quot;accessibility&quot;: [],
  &quot;accessible_venue&quot;: false,
  &quot;add_bcl_url&quot;: false,
  &quot;add_slido&quot;: false,
  &quot;age_policy&quot;: null,
  &quot;american_sign_language&quot;: false,
  &quot;apple_url&quot;: null,
  &quot;audio_description&quot;: false,
  &quot;caption_url&quot;: null,
  &quot;closed_captioned&quot;: false,
  &quot;cpe_credit&quot;: false,
  &quot;has_subtitles&quot;: false,
  &quot;hash_tags&quot;: [],
  &quot;high_sensory_experience&quot;: false,
  &quot;live&quot;: false,
  &quot;long_description&quot;: &quot;The pioneering base-editing method of Alexis Komor, PhD, was recently used to create a custom therapy for an infant with carbamoyl phosphate synthetase 1, a deadly rare disease. Her colleague, Gene Yeo, PhD, favors another new approach: RNA-targeting precision therapeutics, which he used to target ALS &amp; aid a child with developmental epileptic encephalopathy. Both employ AI to discover the roots of polygenic diseases—from the ultra-common like diabetes &amp; heart disease to the ultra-rare—&amp; decode the Dark Genome. More on the promise the technology holds for the future of personalized treatment.&quot;,
  &quot;meeting_url&quot;: null,
  &quot;meeting_url_live&quot;: false,
  &quot;mentorly_url&quot;: null,
  &quot;mobile_audio_url&quot;: null,
  &quot;open_captioned&quot;: false,
  &quot;playlist_tag&quot;: null,
  &quot;rebroadcast&quot;: false,
  &quot;recommended_ids&quot;: [],
  &quot;search_conversions&quot;: null,
  &quot;short_program&quot;: false,
  &quot;slido_url&quot;: null,
  &quot;sort&quot;: &quot;BESPOKE: HOW AI IS USHERING IN THE ERA OF PRECISION GENETICS&quot;,
  &quot;source&quot;: &quot;Official&quot;,
  &quot;squad_up_url&quot;: null,
  &quot;stream_embed&quot;: null,
  &quot;stream_id&quot;: null,
  &quot;stream_url&quot;: null,
  &quot;strobe_warning&quot;: false,
  &quot;subdiscipline&quot;: null,
  &quot;summit&quot;: null,
  &quot;summit_display_name&quot;: null,
  &quot;tags&quot;: [
    {
      &quot;id&quot;: 2114,
      &quot;name&quot;: &quot;AI&quot;,
      &quot;created_at&quot;: &quot;2020-01-17T14:51:44.091-06:00&quot;,
      &quot;updated_at&quot;: &quot;2026-02-18T02:42:15.008-06:00&quot;,
      &quot;sort&quot;: &quot;AI&quot;,
      &quot;alpha&quot;: &quot;A&quot;
    }
  ],
  &quot;talent_attending&quot;: null,
  &quot;title_only&quot;: false,
  &quot;track_display_name&quot;: &quot;Health track sponsored by Eli Lilly&quot;,
  &quot;trailer_id&quot;: null,
  &quot;trailer_url&quot;: null,
  &quot;video_on_demand&quot;: null,
  &quot;vimeo_id&quot;: null,
  &quot;vod&quot;: false,
  &quot;xr_project_type&quot;: null,
  &quot;youtube_id&quot;: null,
  &quot;related_sales_client&quot;: null
}</pre>
  </details>
</section></main>
  <footer class="site-footer">
    <p>Source code: <a href="https://github.com/max2697/SXSW-for-agents">GitHub repository</a></p>
  </footer>
  
</body>
</html>